Abiopharma

ENLIVEN THERAPEUTICS, INC. (ELVN)

Symbol	ELVN
Name	ENLIVEN THERAPEUTICS, INC.
Sector	UNDEFINED
Region	UNDEFINED
Industry	Pharmaceutical Preparations
Address	6200 LOOKOUT ROAD, BOULDER, CO 80301
Telephone	720-647-8519
Fax	—
Email	—
Website	—
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001672619
Description	None

2026-04-30 20:17

📋 Lyssikatos Joseph P (Officer) plans to sell 25K shares of Enliven Therapeutics, Inc. (at $42.40 each, total $1.1M) Filed: Apr 30, 2026 | ID: 000062

2026-04-27 17:11

New Form ARS - Enliven Therapeutics, Inc. Filed: 2026-04-27 AccNo: 0001193125-26-182102 Size: 1 MB

2026-04-27 17:09

New Form DEFA14A - Enliven Therapeutics, Inc. Filed: 2026-04-27 AccNo: 0001193125-26-182081 Size: 179 KB

2026-04-22 00:40

Collins Helen Louise 🟡 adjusted position in 5.0K shares (1 derivative) of Enliven Therapeutics, Inc. (ELVN) at $48.06 Transaction Date: Apr 17, 2026 | Filing ID: 000006

2026-04-15 17:07

New Form PRE 14A - Enliven Therapeutics, Inc. Filed: 2026-04-15 AccNo: 0001193125-26-156995 Size: 2 MB

2026-03-31 20:29

📋 Lyssikatos Joseph P (Officer) plans to sell 25K shares of Enliven Therapeutics, Inc. (at $36.59 each, total $915K) Filed: Mar 31, 2026 | ID: 000031

2026-03-31 20:26

📋 ANDREW PHILLIPS (Ex-Director) plans to sell 26K shares of ENLIVEN THERAPEUTICS, INC. (at $38.55 each, total $1.0M) Filed: Mar 31, 2026 | ID: 003102

2026-03-27 20:57

Collins Helen Louise 🟡 adjusted position in 40.0K shares (1 derivative) of Enliven Therapeutics, Inc. (ELVN) at $35.10 ($1.6M) Transaction Date: Mar 25, 2026 | Filing ID: 000005

2026-03-25 20:29

📋 Collins Helen Louise (Officer) plans to sell 45K shares of Enliven Therapeutics, Inc. (at $31.15 each, total $1.4M) Filed: Mar 25, 2026 | ID: 000026

2026-03-24 20:26

📋 Patel Anish (Officer) plans to sell 100K shares of Enliven Therapeutics, Inc. (at $30.81 each, total $3.1M) Filed: Mar 24, 2026 | ID: 000025